CVS Profit Beats Analyst Estimates on Higher Pharmacy Sales
This article is for subscribers only.
CVS Caremark Corp., the largest provider of prescription drugs in the U.S., posted fourth-quarter profit that topped analysts’ estimates as pharmacy sales rose on new medicines and new customers.
Net income climbed 13 percent to $1.27 billion, or $1.05 a share, from $1.13 billion, or 90 cents, a year earlier, the Woonsocket, Rhode Island-based company said today in a statement. Excluding one-time items, earnings were $1.12 a share, topping by 1 cent the average of 25 estimates compiled by Bloomberg.